Ángel
Carracedo Álvarez
Centro Nacional de Investigaciones Oncológicas
Madrid, EspañaPublicacións en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (28)
2024
-
Meta-analysis of genome-wide association studies for cancer therapy-related cardiovascular dysfunction and functional mapping highlight an intergenic region close to TP63
Scientific Reports, Vol. 14, Núm. 1
-
Novel risk loci for COVID-19 hospitalization among admixed American populations
eLife, Vol. 13
2023
-
A crowdsourcing database for the copy-number variation of the Spanish population
Human Genomics, Vol. 17, Núm. 1
-
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
Breast cancer research : BCR, Vol. 25, Núm. 1, pp. 93
-
A second update on mapping the human genetic architecture of COVID-19
Nature
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
CSVS, a crowdsourcing database of the Spanish population genetic variability
Nucleic acids research, Vol. 49, Núm. D1, pp. D1130-D1137
-
Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk
Journal of the National Cancer Institute, Vol. 113, Núm. 3, pp. 329-337
2019
-
Genome-wide association study of germline variants and breast cancer-specific mortality
British Journal of Cancer, Vol. 120, Núm. 6, pp. 647-657
2017
-
Association analysis identifies 65 new breast cancer risk loci
Nature, Vol. 551, Núm. 7678, pp. 92-94
-
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
Nature Genetics, Vol. 49, Núm. 12, pp. 1767-1778
2016
-
Human genetics: International projects and personalized medicine
Drug Metabolism and Personalized Therapy, Vol. 31, Núm. 1, pp. 3-8
-
Progress in pharmacogenetics: Consortiums and new strategies
Drug Metabolism and Personalized Therapy, Vol. 31, Núm. 1, pp. 17-23
2015
-
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS
Gut, Vol. 64, Núm. 1, pp. 111-120
-
High frequency and founder effect of the CYP3A4∗20 loss-of-function allele in the Spanish population classifies CYP3A4 as a polymorphic enzyme
Pharmacogenomics Journal, Vol. 15, Núm. 3, pp. 288-292
-
Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors
International Journal of Cancer, Vol. 136, Núm. 6, pp. E685-E696
-
Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations
International Journal of Cancer, Vol. 137, Núm. 8, pp. 1870-1878
2014
-
FAS system deregulation in T-cell lymphoblastic lymphoma
Cell Death and Disease, Vol. 5, Núm. 3
2013
2012
-
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer
Breast Cancer Research and Treatment, Vol. 132, Núm. 1, pp. 307-315